Literature DB >> 3904464

Effects of intensified insulin treatment on various lesions of diabetic retinopathy.

O Brinchmann-Hansen, K Dahl-Jørgensen, K F Hanssen, L Sandvik.   

Abstract

Mild background retinopathy was studied prospectively during long-term strict blood glucose control in insulin-dependent diabetes mellitus. Forty-five subjects (21 women and 24 men with a mean age of 26.3 years and a mean duration of diabetes of 12.8 years) were randomly assigned to continuous subcutaneous insulin infusion, multiple injections, and conventional two-injection treatment. Eyes were examined two months before treatment, at the beginning of treatment, and after three, six, and 12 months. A progressive deterioration was found in the two-injection group during the study, but no significant changes were found in patients receiving multiple injections. A transient deterioration occurred after three months of continuous subcutaneous insulin infusion. Soft exudates appeared in 50% of the patients on the two intensified regimens, but no exudates were found in patients given conventional treatment. The morphologic changes seemed to be related to a large and rapid decrease in mean blood glucose or to an increased frequency of hypoglycemia, or both.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3904464     DOI: 10.1016/0002-9394(85)90618-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  18 in total

1.  A laser Doppler velocimetry study of the effect of hypoglycaemia on retinal blood flow in the minipig.

Authors:  G Caldwell; E G Davies; P M Sullivan; A H Morris; E M Kohner
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

2.  Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.

Authors:  K Dahl-Jørgensen; O Brinchmann-Hansen; K F Hanssen; T Ganes; P Kierulf; E Smeland; L Sandvik; O Aagenaes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

3.  Effects of intensified insulin treatment on retinal vessels in diabetic patients.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; K F Hanssen; L Sandvik
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

4.  Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

Authors:  Vassiliki Poulaki; Wenying Qin; Antonia M Joussen; Peter Hurlbut; Stanley J Wiegand; John Rudge; George D Yancopoulos; Anthony P Adamis
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 5.  Diabetic control and microvascular complications: the near-normoglycaemic experience.

Authors:  K F Hanssen; K Dahl-Jørgensen; T Lauritzen; B Feldt-Rasmussen; O Brinchmann-Hansen; T Deckert
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

6.  The medical check-up for potentially serious diabetic retinopathy.

Authors:  I S Begg
Journal:  Can Fam Physician       Date:  1986-07       Impact factor: 3.275

7.  Strict control of glycaemia: effects on blood flow in the large retinal vessels and in the macular microcirculation.

Authors:  J E Grunwald; C E Riva; B L Petrig; A J Brucker; S S Schwartz; S N Braunstein; J DuPont; S Grunwald
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

Review 8.  Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

Authors:  K Jeitler; K Horvath; A Berghold; T W Gratzer; K Neeser; T R Pieber; A Siebenhofer
Journal:  Diabetologia       Date:  2008-03-20       Impact factor: 10.122

9.  Hypoglycaemia exacerbates ischaemic retinal injury in rats.

Authors:  R J Casson; J P M Wood; N N Osborne
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

10.  Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; L Sandvik; K F Hanssen
Journal:  BMJ       Date:  1992-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.